Home » "Kymera Therapeutics"
Tag: “Kymera Therapeutics”
-
31 August 2020 – Ant Group Files for Dual Listing to Potentially Raise $30bn
Listen nowThe Big Ones Cancer test developer Freenome has closed a $270m series C round that included Novartis and existing backers GV, Kaiser Permanente Ventures and…
-
16 March 2020 – Insightec Targets $150m Series F
Listen nowThe Big Ones Insightec is targeting up to $150m in a series F round valuing it at $1.3bn post-money, and has already received a $100m…